SLC5A2 and Hyponatremia: Patients with cirrhosis and ascites often present with concurrent hyponatremia, with sodium levels significantly associated with the prognosis of decompensated liver disease.17,18 SGLT-2 inhibitors may mitigate hyponatremia through sodium-independent water excretion driven by osmotic diuresis.